variant in South Africa

For low- and middle-income countries, just obtaining doses has been a challenge. And now concerns are being raised about the effectiveness of the more affordable AstraZeneca option.

A small study in South Africa has raised concerns about the effectiveness of the AstraZeneca vaccine, particularly in fighting virus variants.